IPO - unknown

Form Type: 8-K

Filing Date: 2025-05-05

Corporate Action: Ipo

Type: New

Accession Number: 000121390025039359

Filing Summary: On April 28, 2025, Inflection Point Acquisition Corp. III (the 'Company') completed its initial public offering (IPO), successfully selling 25,300,000 units that include one Class A ordinary share and one right to receive one-tenth of a Class A ordinary share. The sale price was set at $10.00 per unit, resulting in gross proceeds of $253,000,000. Additionally, a private placement of 740,000 units was conducted simultaneously, generating $7,400,000 in proceeds. The total proceeds, including a deferred underwriter discount, have been placed in a trust account managed by Continental Stock Transfer & Trust Company. An audited balance sheet reflecting these proceeds has been prepared and is included as an exhibit to this report.

Form Type: 424B4

Filing Date: 2025-04-25

Corporate Action: Ipo

Type: New

Accession Number: 000121390025035659

Filing Summary: Inflection Point Acquisition Corp. III is launching an initial public offering (IPO) for 22,000,000 units, priced at $10.00 each, aiming to raise $220,000,000. The company, incorporated in the Cayman Islands, is a special purpose acquisition company (SPAC) that will pursue a business combination such as a merger or asset acquisition but has not selected a specific target. Management is exploring potential partners based on previous discussions during their tenure with Inflection Point Acquisition Corp. II. The units will begin trading on Nasdaq under the symbol 'IPCXU,' with separate trading of Class A ordinary shares and rights commencing on the 52nd day after the prospectus date unless accelerated by the underwriters. Investors can redeem shares at the IPO price depending upon the completion of a business combination, with liquidity provisions including possible redemptions if the business combination is not achieved within 24 months. Notably, this IPO does not offer warrants as typically found in SPAC deals.

Form Type: 8-A12B

Filing Date: 2025-04-24

Corporate Action: Ipo

Type: New

Accession Number: 000121390025034723

Filing Summary: Inflection Point Acquisition Corp. III filed Form 8-A12B for the registration of certain classes of securities under the Securities Exchange Act of 1934. This includes the registration of units, each consisting of one Class A ordinary share and one right to receive one-tenth of one Class A ordinary share, as well as the Class A ordinary shares and rights themselves. The securities will be registered on The Nasdaq Stock Market LLC. The filing references the prospectus and Registration Statement on Form S-1 (File No. 333-283427) initially filed on November 25, 2024, which includes further details about the registered securities. The document is signed by Michael Blitzer, Chairman and CEO, dated April 23, 2025.

Form Type: S-1/A

Filing Date: 2025-04-16

Corporate Action: Ipo

Type: New

Accession Number: 000121390025032632

Filing Summary: Inflection Point Acquisition Corp. III has filed an amendment to its Form S-1 registration statement with the intent to conduct an initial public offering (IPO) of 22,000,000 units priced at $10.00 each, aiming to raise approximately $220,000,000. This special purpose acquisition company (SPAC) plans to use the funds for a merger, share exchange, or business combination without a predetermined target. The offering will provide a redemption option for public shareholders at the completion of the business combination, subject to a maximum of 15% of the outstanding shares without consent. In case of failure to complete a combination within 24 months, the company will redeem the public shares. Despite offering an IPO, there are significant risks mentioned, including potential dilution and conflicts of interest among management due to their financial stakes in founder shares. The company has engaged underwriters including Cantor Fitzgerald & Co., and will seek listing on Nasdaq under the symbol IPCXU. The document includes a comprehensive overview of the business approach, capital structure, and investor rights.

Form Type: S-1/A

Filing Date: 2025-04-08

Corporate Action: Ipo

Type: Update

Accession Number: 000121390025029998

Filing Summary: Inflection Point Acquisition Corp. III is offering 22,000,000 units at $10.00 per unit, aiming to generate approximately $220,000,000 in total. Each unit comprises one Class A ordinary share and one right to receive one-tenth of one Class A ordinary share upon the consummation of an initial business combination. The company, incorporated in the Cayman Islands, is a special purpose acquisition company (SPAC) planning to merge or acquire businesses. No specific target has been chosen, though prior discussions with potential partners associated with Inflection Point Acquisition Corp. II are possible. The proceeds from this offering will be placed in a trust and are intended for business acquisitions, with the potential for up to $250,000 to be used for working capital expenses. To mitigate risks, provisions allow shareholders to redeem shares under certain conditions. If no merger occurs within 24 months, all shares will be redeemed, and management has disclosed various risks associated with the offering and the business combination process. The filing also indicates that the company has identified itself as emerging growth and a smaller reporting company, thus subject to tailored requirements.

Form Type: S-1/A

Filing Date: 2025-01-16

Corporate Action: Ipo

Type: New

Accession Number: 000121390025003974

Filing Summary: Inflection Point Acquisition Corp. III, registered as a Cayman Islands exempted company, is conducting an initial public offering (IPO) to raise $220,000,000 through the offering of 22,000,000 units, each priced at $10. Each unit consists of one Class A ordinary share and one right to receive one-tenth of one Class A ordinary share upon consummation of an initial business combination. The company is a special purpose acquisition entity looking to merge or acquire one or more businesses but has not identified a target yet. The offering includes a 45-day over-allotment option for underwriters to purchase up to an additional 3,300,000 units. The company plans to deposit the proceeds into a trust account and has established a maximum completion window of 24 months from closing for the business combination. If unsuccessful, shares will be redeemed at the price equal to the amount in the trust accounts. The offering is subject to various risks, including substantial dilution for public shareholders due to the founder shares purchased by its sponsor at a nominal price, which could conflict with public shareholders' interests.